Low‐molecular‐weight heparin for asymptomatic cerebral sinovenous thrombosis in a neonate.

The article presents case study of patient was a 14-day-old female neonate with no specific abnormalities, who had growth restriction during her fetal period. It mentions diagnosis with neonatal cerebral sinovenous thrombosis (CSVT) because of its lower risk of bleeding compared with unfractionated heparin.